Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

49.59
Delayed Data
As of Aug 31
 -0.78 / -1.55%
Today’s Change
44.80
Today|||52-Week Range
76.69
-12.03%
Year-to-Date

Today’s Trading

Previous close50.37
Today’s open50.59
Day’s range49.45 - 51.66
Volume5,784,934
Average volume (3 months)7,138,015
Market cap$24.8B
Dividend yield--
Data as of 4:14pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+18.03%
Earnings growth (next 5 years)+10.65%
Revenue growth (last year)+12.42%
P/E ratio21.4
Price/Sales2.89
Price/Book5.80

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-0.91-1.99%
PRGOPerrigo Company PLC-2.45-1.32%
INCYIncyte Corp-3.74-3.12%
BMRNBiomarin Pharmaceuti...-3.94-2.96%
Data as of 4:04pm ET, 08/31/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)$1.35
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

Partner Offers